Aortic valve replacement for aortic stenosis in France – Influence of centers’ volumes on TAVR adoption rate and outcomes - 31/12/22
, V. Nguyen 2, H. Eltchaninoff 3, I. Burwash 4, M. Michel 5, E. Durand 6, M. Gilard 7, B. Iung 8, A. Cribier 3, K. Chevreul 9, D. Messika-Zeitoun 10Résumé |
Introduction |
Over the last decade, transcatheter aortic valve replacement (TAVR) became the recommended procedure for AVR in selected patients’ populations.
Objective |
It is unknown whether TAVR adoption rate and variability in outcomes is influenced by centers’ volume.
Method |
From a French administrative hospital-discharge database, we collected all AVR performed in France between 2007 and 2019. Centers were stratified to terciles based on their annual SAVR per year per center during 2007–2009 (“pre-TAVR era”).
Results |
There was 218,489 AVRs (153,747 SAVR and 74,732 TAVR) performed in 46 centers between 2007–2019. Number of total AVR and even more so number of number of TAVR significantly and linearly increased from 2007 to 2019 in all terciles but faster in the high volume tercile (+17, +17 and +31 AVR/center/year in the low, middle and high terciles respectively, P [ANCOVA]<0.001; +11, +19 and +33 TAVR/center/year in the low, medium and high tercile respectively, P [ANCOVA]<0.00, Fig. 1). Charlson index declined from 2010 to 2019 (from 1.35±1.42 to 0.65±1.04, from 1.21±1.40 to 0.65±1.05 and from 1.53±1.58 to 0.81±1.21, in the low, middle and high terciles, P for trend<0.001, 0.021, and<0.001, respectively). Charlson score in the years 2017–2019, was higher in the high than middle and low terciles (0.87±1.22, 0.76±1.11 and 0.65±1.04, respectively, P<0.0001). The in-hospital mortality rate for TAVR significantly declined from 2010 to 2019 for TAVR in all terciles (from 8.3% to 2.1%, from 7.5% to 2.5% and from 8.2% to 2.1% for low, middle and high TAVR terciles, respectively; P for trend=0.002, 0.001 and<0.001, respectively, Fig. 2). After adjusting for age, sex and Charlson score, mortality was higher in the low tercile compared with middle and high terciles (OR: 1.15, P<0.001, confidence interval [CI]: 1.0–1.2, and OR: 1.18, P<0.001, CI: 1.1–1.2, respectively).
Conclusion |
From 2007 to 2019 total AVR linearly increased, mostly due to increase in TAVR, irrespective of centers’ volume, but increase rate was higher in high volume centers. A constant decline in patients risk profile, with a striking decrease in mortality rate, was observed in all volume terciles. High-volume centers patients’ have higher risk profile, with adjusted mortality slightly lower than medium and low volume centers.
Le texte complet de cet article est disponible en PDF.Plan
Vol 15 - N° 1
P. 121 - janvier 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
